Order byBest matchMost fresh
BioSpace12h
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
Roche boosts US presence with new $700 million North Carolina facility
Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies.
Biopharma giant Roche pledges 420-job factory in fast-growing Wake County town
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.
AS Monaco and Roche Bobois extend their partnership until 2027
AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international reputation, are delighted to announce the extension of their partnership for a
Daily Journal1d
Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.
Explore more
Becker's Hospital Review8h
Roche to invest up to $550M in diagnostics site
Roche will invest up to $550 million in its Indianapolis diagnostics site by 2030 to expand production of its continuous glucose monitoring systems. The Indianapolis location serves as the headquarters for Roche Diagnostics and currently produces 5.
BioSpace1d
Roche’s Genentech Earmarks $700M for North Carolina Plant as Billion-Dollar US Pledge Hangs in Balance
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.
The Punch8h
NHIA, Roche sign MoU to improve access to cancer care, treatment
The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational healthcare company, Roche, to enhance access to affordable cancer care and treatment.
Feedback